Read by QxMD icon Read

travel vaccines

Anita E Heywood, Hans Nothdurft, Dominique Tessier, Melissa Moodley, Lars Rombo, Cinzia Marano, Laurence De Moerlooze
BACKGROUND: Knowledge about the travel-associated risks of hepatitis A and B, and the extent of pre-travel health-advice being sought may vary between countries. METHODS: An online survey was undertaken to assess the awareness, advice-seeking behaviour, rates of vaccination against hepatitis A and B and adherence rates in Australia, Finland, Germany, Norway, Sweden, the UK and Canada between August and October 2014. Individuals aged 18-65 years were screened for eligibility based on: travel to hepatitis A and B endemic countries within the past 3 years, awareness of hepatitis A, and/or combined hepatitis A&B vaccines; awareness of their self-reported vaccination status and if vaccinated, vaccination within the last 3 years...
July 2016: Journal of Travel Medicine
Hainv Gao, Hangping Yao, Shigui Yang, Lanjuan Li
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a novel zoonotic pathogen. In 2012, the infectious outbreak caused by MERS-CoV in Saudi Arabia has spread to more than 1600 patients in 26 countries, resulting in over 600 deaths.Without a travel history, few clinical and radiological features can reliably differentiate MERS from SARS. But in real world, comparing with SARS, MERS presents more vaguely defined epidemiology, more severe symptoms, and higher case fatality rate. In this review, we summarize the recent findings in the field of MERS-CoV, especially its molecular virology, interspecies mechanisms, clinical features, antiviral therapies, and the further investigation into this disease...
October 1, 2016: Frontiers of Medicine
Aleš Chrdle, Vaclav Chmelik, Daniel Ruzek
Tick-borne encephalitis (TBE) is an acute febrile illness with neurological manifestations that is prevalent in forested areas of moderate climate in Europe and Asia. TBE virus is transmitted by ticks and rarely by unpasteurized milk and dairy products. The disease burden is attributed mainly to resulting long-term disability, especially in individuals over 50 years of age. Currently, there is no causative treatment, but a very effective vaccination is available with a good safety profile. The vaccination requires three basic doses to be fully effective and regular boosters afterwards...
August 15, 2016: Human Vaccines & Immunotherapeutics
Gregory Valentine, Lucila Marquez, Mohan Pammi
Zika Virus (ZIKV), previously the cause of only rare and sporadic human infections, is now considered a Public Health Emergency of International Concern. Over the past two years, ZIKV has become a pandemic encompassing much of the Americas. ZIKV is now proven to cause microcephaly and ophthalmic anomalies in the newborn. Hydrops fetalis, developmental delay, and other anomalies are increasingly being attributed to ZIKV infection in fetuses and neonates. Sequelae of congenital infection and rapid spread of ZIKV throughout the Americas has catapulted Zika virus concerns to the forefront of the medical community...
October 7, 2016: Expert Review of Anti-infective Therapy
Kimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, Eun Sung Yang, Rebecca S Pelc, Christina R DeMaso, Leda R Castilho, Peter Abbink, Michael Boyd, Ramya Nityanandam, David N Gordon, John Robert Gallagher, Xuejun Chen, John-Paul Todd, Yaroslav Tsybovsky, Audray Harris, Yan-Jang S Huang, Stephen Higgs, Dana L Vanlandingham, Hanne Andersen, Mark G Lewis, Rafael De La Barrera, Kenneth H Eckels, Richard G Jarman, Martha C Nason, Dan H Barouch, Mario Roederer, Wing-Pui Kong, John R Mascola, Theodore C Pierson, Barney S Graham
Zika virus (ZIKV) was identified as a cause of congenital disease during the explosive outbreak in the Americas and Caribbean that began in 2015. Because of the ongoing fetal risk from endemic disease and travel-related exposures, a vaccine to prevent viremia in women of childbearing age and their partners is imperative. We found that vaccination with DNA expressing the premembrane and envelope proteins of ZIKV was immunogenic in mice and nonhuman primates, and protection against viremia after ZIKV challenge correlated with serum neutralizing activity...
October 14, 2016: Science
Leigh Daynes
Over the last year, hundreds of thousands of refugees fleeing war and persecution have travelled from the Middle East to Europe. Arduous journeys and poor living conditions are causing myriad health problems and access to basic healthcare is extremely limited for those on the move. At every stage of the journey, people are suffering, including after they settle in Europe. The difficulty in managing non-communicable diseases means that some refugees are not getting the treatment they need, which in the long term can have a significant adverse impact on their health...
October 2016: Clinical Medicine: Journal of the Royal College of Physicians of London
Lin H Chen, Pauline V Han, Mary E Wilson, Rhett J Stoney, Emily S Jentes, Christine Benoit, Winnie W Ooi, Elizabeth D Barnett, Davidson H Hamer
BACKGROUND: The Boston Area Travel Medicine Network surveyed travelers on travel-related health problems. METHODS: Travelers were recruited 2009-2011 during pre-travel consultation at three clinics. The investigation included pre-travel data, weekly during-travel diaries, and a post-travel questionnaire. We analyzed demographics, trip characteristics, health problems experienced, and assessed the relationship between influenza vaccination, influenza prevention advice, and respiratory symptoms...
October 2, 2016: Travel Medicine and Infectious Disease
Cath Jackson, Lisa Dyson, Helen Bedford, Francine M Cheater, Louise Condon, Annie Crocker, Carol Emslie, Lana Ireland, Philippa Kemsley, Susan Kerr, Helen J Lewis, Julie Mytton, Karen Overend, Sarah Redsell, Zoe Richardson, Christine Shepherd, Lesley Smith
BACKGROUND: Gypsies, Travellers and Roma (referred to as Travellers) are less likely to access health services, including immunisation. To improve immunisation rates, we need to understand what helps and hinders individuals in these communities in taking up immunisations. AIMS: (1) Investigate the barriers to and facilitators of acceptability and uptake of immunisations among six Traveller communities across four UK cities; and (2) identify possible interventions to increase uptake of immunisations in these Traveller communities that could be tested in a subsequent feasibility study...
September 2016: Health Technology Assessment: HTA
(no author information available yet)
Many patients would forgo travel vaccination if they had to pay more than a standard prescription charge for it, according to recently published research.
July 12, 1995: Nursing Standard
(no author information available yet)
Active immunisation with oral cholera vaccine might give partial protection against travellers' diarrhoea, reseachers from Finland say.
December 11, 1991: Nursing Standard
Devrim Emel Alici, Abdullah Sayiner, Serhat Unal
Immunization is an important component of preventive healthcare services aiming to prevent and eventually eradicate infectious diseases by immunizing people before they become infected. Although immunization is an integral part of children's healthcare, this fact is underrated, even ignored in adults. In Turkey, adult immunization is available only for certain high risk groups such as health care professionals and populations aged >65 years and under certain conditions including pregnancy, military service, travel-pilgrimage, and employment procedures...
September 26, 2016: Human Vaccines & Immunotherapeutics
Grazia Tosone, Silvia Mascolo, Roberto Bruni, Stefania Taffon, Michele Equestre, Maria Elena Tosti, Anna Rita Ciccaglione, Fiorella Martucci, Alfonso Liberti, Maria Donata Iannece, Raffaele Orlando
Hepatitis A virus is a widely occurring disease, with different prevalence rates between countries in the North and West and those in the South and East. In Italy endemicity is low/medium, but not homogeneously distributed: in the northern/central regions a large hepatitis A outbreak due to genotype IA, related to the consumption of contaminated mixed frozen berries, occurred between 2013 and 2014, whereas in southern Italian regions recurrent outbreaks of hepatitis A, due to the IB genotype, still result from consumption of raw seafood...
September 1, 2016: Le Infezioni in Medicina
(no author information available yet)
No abstract text is available yet for this article.
September 23, 2016: Relevé épidémiologique Hebdomadaire
Engin Burak Selcuk, Uner Kayabas, Hulisi Binbasioglu, Baris Otlu, Yasar Bayindir, Bulent Bozdogan, Mehmet Karatas
BACKGROUND: The number of international travellers is increasing worldwide. Although health risks related to international travel are important and generally well-understood, the perception of these risks was unclear among Turkish travellers. We aimed to evaluate the attitudes and health risk awareness of Turkish travellers travelling to African countries. METHOD: A survey was performed of Turkish travellers bound for Africa from Istanbul International Ataturk Airport in July 2013...
September 20, 2016: Travel Medicine and Infectious Disease
Nahla Khamis Ibrahim
OBJECTIVE: To describe Zika Virus (ZIKV) epidemiology, current phobia, and the required preparedness for its prevention during the upcoming Mass Gathering (MG) events. METHODS: Electronic databases of PubMed, WHO, CDC, Pan American Health Organization (PAHO), Google, and Cochrane library were extensively searched for ZIKV. Articles were reviewed, scrutinized and critically appraised and the most relevant articles were utilized. RESULTS: ZIKV is an emerging Flavivirus which was first isolated from Uganda in 1947...
July 2016: Pakistan Journal of Medical Sciences Quarterly
K C Dixon, R Mullis, T Blumenfeld
BACKGROUND: Compared to the general population, the Traveller community has substantial health inequalities. Vaccination coverage in Traveller children is estimated to be low and Travellers are at higher risk of vaccine-preventable diseases due to their social circumstances. METHODS: Audit of vaccination history of Traveller (n = 214) and non-Traveller (n = 776) children registered at a general practice in England. The Green Book childhood immunization schedule was used as a reference standard...
September 18, 2016: Journal of Public Health
Jason A Trubiano, Douglas Johnson, Asma Sohail, Joseph Torresi
BACKGROUND: Solid organ transplant (SOT) recipients are often heavily immunosuppressed and consequently at risk of serious illness from vaccine preventable viral and bacterial infections or with endemic fungal and parasitic infections. We review the literature to provide guidance regarding the timing and appropriateness of vaccination and pathogen avoidance related to the immunological status of SOT recipients. METHODS: A PUBMED search ([Vaccination OR vaccine] AND/OR ["specific vaccine"] AND/OR [immunology OR immune response OR cytokine OR T lymphocyte] AND transplant was performed...
June 2016: Journal of Travel Medicine
Ana Rita de Toledo-Piza, Cristina Adelaide Figueiredo, Maria Isabel de Oliveira, Giuseppina Negri, Gislene Namiyama, Mariana Tonelotto, Karina de Senna Villar, Henrique Krambeck Rofatto, Ronaldo Zucatelli Mendonça
Measles is a viral disease highly contagious spread by respiratory transmission. Although infection can be controlled by vaccination, numerous cases of measles have been registered in many areas of the world, highlighting the need for additional interventions. Terrestrial gastropods exude mucus on their body surface when traveling, to protect the body from mechanical injury, desiccation or contact with harmful substances. The mucus of mollusks has been studied as a source of new natural compounds with diverse biological activities...
October 2016: Antiviral Research
Michael R Hollingdale, Martha Sedegah, Keith Limbach
INTRODUCTION: Malaria remains a major threat to endemic populations and travelers, including military personnel to these areas. A malaria vaccine is feasible, as radiation attenuated sporozoites induce nearly 100% efficacy. AREAS COVERED: This review covers current malaria clinical trials using adenoviruses and pre-clinical research. Heterologous prime-boost regimens, including replication-deficient human adenovirus 5 (HuAd5) carrying malaria antigens, are efficacious...
September 8, 2016: Expert Review of Vaccines
Michael Freuler, Susan De Crom, Christoph Hatz, Silja Bühler
QUESTION UNDER STUDY: In Switzerland, vaccination against varicella is not recommended in the basic immunisation schedule. However, for individuals aged 11-40 years who do not have a reliable varicella history the Swiss Federal Office of Public Health recommends either (i) a vaccination or (ii) a serology test and vaccination of those with a negative result. In the Travel Clinic of the University of Zurich, the second strategy is followed. In this study we retrospectively assessed the overall percentage of individuals with varicella-specific antibodies despite a negative history and we examined the influence of age, number of siblings, order of siblings, age difference to siblings and nationality on varicella seropositivity...
2016: Swiss Medical Weekly
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"